Community Advisory Board
The mission of the Community Advisory Board (CAB) is to encourage community involvement in all aspects of AIDS clinical trials in order to advance research.
The CAB seeks participation from groups that have traditionally been underrepresented in clinical trials. Unfortunately, people of color, women and others are most in need of clinical trial intervention.
The CAB at the Cornell Clinical Trial Unit is currently composed of a variety of individuals from all walks of life who have experienced HIV/AIDS. CAB members and guests have found meetings to be both informative and worthwhile. A recent survey showed that CAB members were eager to learn about different and new clinical trials and were interested in increasing the participation of woman and minority groups in the trials.
Collaborators and Funding Sources
Working with an extensive network of physicians throughout New York City and the United States, the Cornell Clinical Trials Unit (CCTU) receives regular referrals of patients for its clinical trials.
Our nationally and internationally recognized excellence in medical education, research, and patient care relies on philanthropy, at all levels of giving, to maintain its outstanding quality. In addition, the CCTU has well established partnerships and has received funding from these agencies:
The Gay Men's Health Crisis (GMHC), the nation's largest and oldest service organization addressing the AIDS epidemic (collaboration)
National Institutes of Health's AIDS Clinical Trials Group (ACTG) (funding)
The Dutch International AIDS Treatment Evaluation Center (IATEC) (funding)
The New York City Department of Health
The American Foundation for AIDS Research (amfAR)
Health Resources and Services Administration's AIDS Education and Training Center (AETC)(funding)
Many high-quality, industry-sponsored Phase I, II and III treatment studies
Additionally, donors have made a tremendous difference in our ability to continue our life- saving work. Please help us as we continue to pursue excellence in medicine during our second decade of achievement. Click GIVE NOW to donate to the Cornell Clinical Trials Unit.